GlyCosmos Portal

Source	Last Updated
GlyConnect	April 19, 2023
GlycoProtDB	October 1, 2021
GlyGen	June 4, 2024
The O-GlcNAc Database	June 3, 2024
UniProt	June 4, 2024

Displaying entries **16826 - 16850** of **18496** in total

« First

‹ Prev

…

670

671

672

673

674

675

676

677

678

…

Next ›

Last »
UniProt ID	Protein Name	Gene Symbol ▼	Organism	No. of Glycosylation Sites	No. of GlyTouCan IDs	Disease Ontology
P27824	Calnexin	CANX	Homo sapiens (human)	11	5	Charcot-Marie-Tooth disease X-linked dominant 1 Charcot-Marie-Tooth disease X-linked dominant 6 Charcot-Marie-Tooth disease X-linked recessive 2 Charcot-Marie-Tooth disease X-linked recessive 3 Charcot-Marie-Tooth disease X-linked recessive 4 Charcot-Marie-Tooth disease X-linked recessive 5 Charcot-Marie-Tooth disease axonal type 2C Charcot-Marie-Tooth disease axonal type 2F Charcot-Marie-Tooth disease axonal type 2H Charcot-Marie-Tooth disease axonal type 2K Charcot-Marie-Tooth disease axonal type 2L Charcot-Marie-Tooth disease axonal type 2N Charcot-Marie-Tooth disease axonal type 2O Charcot-Marie-Tooth disease axonal type 2P Charcot-Marie-Tooth disease axonal type 2Q Charcot-Marie-Tooth disease axonal type 2T Charcot-Marie-Tooth disease axonal type 2U Charcot-Marie-Tooth disease dominant intermediate A Charcot-Marie-Tooth disease dominant intermediate B Charcot-Marie-Tooth disease dominant intermediate C Charcot-Marie-Tooth disease dominant intermediate D Charcot-Marie-Tooth disease dominant intermediate E Charcot-Marie-Tooth disease dominant intermediate F Charcot-Marie-Tooth disease recessive intermediate B Charcot-Marie-Tooth disease recessive intermediate C Charcot-Marie-Tooth disease recessive intermediate D Charcot-Marie-Tooth disease type 1A Charcot-Marie-Tooth disease type 1B Charcot-Marie-Tooth disease type 1C Charcot-Marie-Tooth disease type 1D Charcot-Marie-Tooth disease type 1E Charcot-Marie-Tooth disease type 1F Charcot-Marie-Tooth disease type 2 Charcot-Marie-Tooth disease type 2A1 Charcot-Marie-Tooth disease type 2A2A Charcot-Marie-Tooth disease type 2B1 Charcot-Marie-Tooth disease type 2B2 Charcot-Marie-Tooth disease type 2B Charcot-Marie-Tooth disease type 2D Charcot-Marie-Tooth disease type 2E Charcot-Marie-Tooth disease type 2I Charcot-Marie-Tooth disease type 2J Charcot-Marie-Tooth disease type 2R Charcot-Marie-Tooth disease type 2Y Charcot-Marie-Tooth disease type 4A Charcot-Marie-Tooth disease type 4B1 Charcot-Marie-Tooth disease type 4B2 Charcot-Marie-Tooth disease type 4B3 Charcot-Marie-Tooth disease type 4C Charcot-Marie-Tooth disease type 4D Charcot-Marie-Tooth disease type 4E Charcot-Marie-Tooth disease type 4F Charcot-Marie-Tooth disease type 4G Charcot-Marie-Tooth disease type 4H Charcot-Marie-Tooth disease type 4J Charcot-Marie-Tooth disease type 4K Charcot-Marie-Tooth disease Lyme disease MASA syndrome Marfan syndrome Zollinger-Ellison syndrome abdominal obesity-metabolic syndrome 1 absence epilepsy acute myocardial infarction adult medulloblastoma agenesis of the corpus callosum with peripheral neuropathy arteriolosclerosis arteriosclerosis arteriosclerotic cardiovascular disease atherosclerosis bone osteosarcoma breast adenocarcinoma breast cancer breast carcinoma bronchus cancer bronchus carcinoma cancer central nervous system lymphoma cervical squamous cell carcinoma cervix uteri carcinoma in situ childhood absence epilepsy childhood medulloblastoma childhood osteosarcoma cone-rod dystrophy coronary artery disease coronary thrombosis diabetes mellitus diabetic angiopathy diabetic ketoacidosis embryoma exanthema subitum fundus albipunctatus giant cell glioblastoma glioblastoma head and neck squamous cell carcinoma hepatocellular carcinoma hereditary neuropathy with liability to pressure palsies hereditary sensory and autonomic neuropathy type 2 high grade glioma hyperinsulinism interstitial lung disease keratosis follicularis liver cancer lung adenocarcinoma lung benign neoplasm lung cancer lung carcinoma lymphoma measles medulloblastoma medullomyoblastoma melanoma melanotic medulloblastoma mongolian spot monoclonal gammopathy of uncertain significance motor peripheral neuropathy mucopolysaccharidosis II mucopolysaccharidosis III mucopolysaccharidosis IV mucopolysaccharidosis VI mucopolysaccharidosis multiple myeloma multiple sclerosis myocardial infarction nephrogenic diabetes insipidus neuropathy nodular prostate obsolete hereditary motor and sensory neuropathy with agenesis of the corpus callosum oculocutaneous albinism type IA oculocutaneous albinism osteosarcoma peripheral nervous system disease platelet-type bleeding disorder 11 platelet-type bleeding disorder 3 platelet-type bleeding disorder 8 platelet-type bleeding disorder 9 polyneuropathy post-traumatic stress disorder progressive muscular atrophy prostate cancer prostate carcinoma prostatic adenoma pseudoachondroplasia pseudoxanthoma elasticum renal tubular acidosis retinitis pigmentosa rubella silent myocardial infarction situs inversus skin melanoma spinal muscular atrophy stomach cancer stomach carcinoma tuberous sclerosis 1 tuberous sclerosis type 2 diabetes mellitus vitiligo von Willebrand's disease
K7EN15	Calcium activated nucleotidase 1	CANT1	Homo sapiens (human)	1	0
Q8WVQ1	Soluble calcium-activated nucleotidase 1	CANT1 SHAPY	Homo sapiens (human)	2	5
O75155	Cullin-associated NEDD8-dissociated protein 2	CAND2 KIAA0667 TIP120B	Homo sapiens (human)	1	2
Q86VP6	Cullin-associated NEDD8-dissociated protein 1	CAND1 KIAA0829 TIP120 TIP120A	Homo sapiens (human)	1	1
Q9Y6Y1	Calmodulin-binding transcription activator 1	CAMTA1 KIAA0833	Homo sapiens (human)	1	0
Q9P1Y5	Calmodulin-regulated spectrin-associated protein 3	CAMSAP3 KIAA1543	Homo sapiens (human)	5	1
Q08AD1	Calmodulin-regulated spectrin-associated protein 2	CAMSAP2 CAMSAP1L1 KIAA1078	Homo sapiens (human)	1	1
Q5T5Y3	Calmodulin-regulated spectrin-associated protein 1	CAMSAP1	Homo sapiens (human)	4	2
P49913	Cathelicidin antimicrobial peptide	CAMP CAP18 FALL39	Homo sapiens (human)	1	2
P49069	Guided entry of tail-anchored proteins factor CAMLG	CAMLG CAML GET2	Homo sapiens (human)	0	1
Q8NCB2	CaM kinase-like vesicle-associated protein	CAMKV	Homo sapiens (human)	5	1
Q7Z624	Calmodulin-lysine N-methyltransferase	CAMKMT C2orf34 CLNMT	Homo sapiens (human)	1	1
Q96RR4	Calcium/calmodulin-dependent protein kinase kinase 2	CAMKK2 CAMKKB KIAA0787	Homo sapiens (human)	1	1
Q8N5S9	Calcium/calmodulin-dependent protein kinase kinase 1	CAMKK1 CAMKKA	Homo sapiens (human)	0	1
Q16566	Calcium/calmodulin-dependent protein kinase type IV	CAMK4 CAMK CAMK-GR CAMKIV	Homo sapiens (human)	7	1
Q96S95	Calcium/calmodulin-dependent protein kinase II inhibitor 2	CAMK2N2	Homo sapiens (human)	0	1
Q13555	Calcium/calmodulin-dependent protein kinase type II subunit gamma	CAMK2G CAMK CAMK-II CAMKG	Homo sapiens (human)	1	2
Q13557	Calcium/calmodulin-dependent protein kinase type II subunit delta	CAMK2D CAMKD	Homo sapiens (human)	3	1
Q13554	Calcium/calmodulin-dependent protein kinase type II subunit beta	CAMK2B CAM2 CAMK2 CAMKB	Homo sapiens (human)	5	1
Q9UQM7	Calcium/calmodulin-dependent protein kinase type II subunit alpha	CAMK2A CAMKA KIAA0968	Homo sapiens (human)	1	1
Q8IU85	Calcium/calmodulin-dependent protein kinase type 1D	CAMK1D CAMKID	Homo sapiens (human)	1	1
Q9NYX4	Neuron-specific vesicular protein calcyon	CALY DRD1IP	Homo sapiens (human)	1	0
Q6IAW5	Calumenin	CALU	Homo sapiens (human)	1	0
O43852	Calumenin	CALU	Homo sapiens (human)	11	116

Table Filtering

GlyTouCan

GlyComb

GlycoPOST

UniCarb-DR

All Resources

Other Information

Tools

Search Tools

International Collaboration

Acknowledgements